COVID‑19 Cicada Variant Spreads
The BA.3.2 variant of COVID-19, nicknamed Cicada, features significant genetic changes that may impact vaccine effectiveness for patients with chronic lung disease.
The BA.3.2 variant of COVID-19, nicknamed Cicada, features significant genetic changes that may impact vaccine effectiveness for patients with chronic lung disease.
A 10-year analysis of emergency department data shows one sport poses a greater risk of severe injury to youth athletes.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
Research using lung-on-a-chip technology shows that mechanical stress from asthma attacks causes tissue damage independently of inflammation.
Research involving 2.5 million patients found no increase in serious adverse events when receiving both COVID-19 and influenza vaccinations during the same visit.
Remote monitoring did not increase the time spent at home after discharge among patients hospitalized with sepsis or lower respiratory tract infection, according to results from a randomized clinical trial of 1,286 adults.
Risk-based models may improve screening efficiency compared to current guidelines, but accuracy issues remain for specific racial and ethnic populations.
The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.